earnings

NASDAQ · ATRA
Atara Biotherapeutics, Inc.
Healthcare · Biotechnology
$9.37
Down-$0.38 (-3.90%)
Updated Oct 8, 2026, 7:32 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128.72M
- P/E ratio
- 37.58
- Dividend yield
- 0.00%
- 52-week range
- $4.30 – $12.45
- Volume
- 11.45K
- Avg. volume
- 71.88K
Price performance · ATRA
ATRA price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
ATRA closed at $9.37 after 21 trading sessions, down 5.45% for the selected period.
- Last close
- $9.37
- Period change
- -5.45%
- Period low
- $8.05
- Period high
- $10.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $9.62 | $9.7499 | $9.37 | $9.37 | 11.45K |
| Oct 6, 2026 | $9.41 | $9.79 | $9.05 | $9.75 | 47.6K |
| Oct 5, 2026 | $9.59 | $9.63 | $8.95 | $9.40 | 39.32K |
| Oct 2, 2026 | $8.46 | $9.675 | $8.25 | $9.48 | 85.75K |
| Oct 1, 2026 | $8.73 | $9.20 | $8.23 | $8.46 | 90.93K |
| Sep 30, 2026 | $8.08 | $8.7099 | $7.83 | $8.50 | 29.3K |
| Sep 29, 2026 | $8.33 | $8.8212 | $7.89 | $8.05 | 56.45K |
| Sep 28, 2026 | $8.69 | $8.705 | $8.3361 | $8.37 | 23.53K |
| Sep 25, 2026 | $8.60 | $8.99 | $8.535 | $8.81 | 31.2K |
| Sep 24, 2026 | $8.60 | $8.86 | $8.33 | $8.54 | 20.78K |
| Sep 23, 2026 | $8.92 | $8.95 | $8.40 | $8.56 | 40.47K |
| Sep 22, 2026 | $9.30 | $9.60 | $8.93 | $8.93 | 27.27K |
| Sep 21, 2026 | $9.69 | $9.92 | $9.30 | $9.38 | 29.67K |
| Sep 18, 2026 | $9.73 | $10.19 | $9.60 | $9.69 | 37.77K |
| Sep 17, 2026 | $10.28 | $10.28 | $9.41 | $9.71 | 26.42K |
| Sep 16, 2026 | $9.50 | $10.37 | $9.07 | $10.11 | 116.75K |
| Sep 15, 2026 | $9.21 | $9.88 | $8.92 | $9.44 | 56.06K |
| Sep 14, 2026 | $9.09 | $9.71 | $9.07 | $9.25 | 50.85K |
| Sep 11, 2026 | $10.00 | $10.00 | $9.38 | $9.38 | 16.03K |
| Sep 10, 2026 | $9.94 | $9.94 | $9.52 | $9.89 | 23.21K |
| Sep 9, 2026 | $10.27 | $10.43 | $9.76 | $9.91 | 68.51K |
Latest ATRA news
The latest Smart Investors Daily articles mentioning ATRA.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

